Pei Hui

9PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyFoetal development and medicineInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Jan 07, 2026
Uterine teratomas: a report of clinicopathological features of five tumours.

Lawrence Hsu Lin, Kyle M Devins, Gulisa Turashvili

|Oct 11, 2025
STR genotyping diagnosis of hydatidiform moles: an assessment of 2871 consecutive products of conceptions.

Razie Amraei, Na Niu, Mitchel Clark

|Jul 20, 2024
Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?

Agnes Nagy, Na Niu, Tong Sun

|Apr 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.

Levent Mutlu, Diego D Manavella, Stefania Bellone

Pageof 2

Frequent Collaborators

6 joint publications

Natalia Buza

3 joint publications

Alessandro D Santin

3 joint publications

Mitchell Clark

3 joint publications

Elena S Ratner